Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
abnormal, absent, academia, Accommodation, accretion, addiction, afflicted, airway, analogue, antibiotic, APIC, APT, arterial, aspart, auto, bacterial, basal, belief, binomial, bioterrorism, Canadian, capture, CEO, cessation, CF, children, chloride, choice, choose, cigarette, cipro, clarification, clause, communication, conclusion, confident, copier, coughing, count, counter, damage, De, death, digestion, dominated, droplet, educational, elevated, Elmer, EU, exertion, explicitly, FAS, fastest, fatigue, frequency, FSP, genetic, habit, hand, HCQ, highest, housed, Hydrochloroquine, Hydroxychloroquine, hypertension, inflammation, intelligence, interaction, intravenously, irreversible, left, Machinery, Mannkind, marker, median, micron, mid, Montfort, morbidity, narrowing, nicotine, NPH, Outcome, outflow, PAH, passage, Perkin, phobia, pm, pool, proof, prostacyclin, protein, PST, ramping, reelection, reengineered, Reform, Remodulin, repayment, Repricing, resistant, resold, retitled, retrospective, rheumatoid, simplified, slightly, smoke, smoked, smoking, standing, stay, steroid, sticky, stimuli, supplement, symptom, tar, thick, titrate, titration, tobacco, tolerability, treprostinil, undeclared, understanding, unearned, unmet, untreated, vary, view, viral, wean, wheezing, withhold
Removed:
Aachen, abstract, Adjustable, adversely, aggressively, alfa, alpha, America, Amgen, Avenue, Bayer, behavior, benson, bioavailability, Bureau, calculated, Catalina, Chemtrak, Colorado, compute, computing, contractually, creation, DeMontfort, depositing, discontinue, dornase, Dortmund, Electric, encompassed, endocrine, expiring, explanation, formal, GE, gene, geneRx, Germany, impacted, Institute, interferon, Iridex, joined, joint, Juelich, Kohl, lessening, listing, magnitude, Marburg, Max, Milligin, Norma, North, notice, oncology, organizational, OTC, Pepperdine, Pfizer, pink, Planck, proactive, pursued, Quotation, Realization, remedy, resource, retired, SAB, scale, session, spent, stan, submitted, suitability, taught, thirty, undergraduate, West, Winton
Filing tables
Filing exhibits
Related press release
ARDMQ similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-76584, No. 333-69614, No. 333-52081, No. 333-72037, No. 333-48384 and No. 333-122223; and Form S-8 No. 333-85244, No. 333-63116, No. 333-15947, No. 333-62039, No. 333-92169 and No. 333-128525) of Aradigm Corporation of our report dated March 10, 2006, with respect to the financial statements of Aradigm Corporation included in this Annual Report (Form 10-K) for the year ended December 31, 2005.
/s/ Ernst & Young LLP
Palo Alto, California
March 30, 2006